Patent · US Active

Glycotargeting therapeutics

US11654188B2 · kind B2 · utility

1Cited by

140References

20Claims

0Family size

Assignees

ECOLE POLYTECHNIQUE FEDERALE DE LAUSANNE (EPFL) · CH
Anokion SA · CH

Inventors

Jeffrey A. Hubbell · Austin, US
David Scott Wilson · Redwood City, US
Stephane Kontos · Ecublens, CH
Kristen Marie Lorentz · Cambridge, US
Shuning Gai · Gland, CH

Key dates

Filing date	Dec 20, 2019
Grant date	May 23, 2023
Priority date	—
Expiry date	Dec 20, 2039

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K2319/01
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Glycotargeting therapeutics are useful in the treatment of transplant rejection, autoimmune disease, food allergy, and immune response against a therapeutic agent.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.